| Lawrence M Saltis, MD | |
|
701 White Pond Dr, Suite 300, Akron, OH 44320-1127 | |
| (330) 572-1011 | |
| (330) 572-1018 |
| Full Name | Lawrence M Saltis |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 53 Years |
| Location | 701 White Pond Dr, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093777690 | NPI | - | NPPES |
| 0218320 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 35033727S (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Reserve Hospital | Cuyahoga falls, OH | Hospital |
| Summa Health System | Akron, OH | Hospital |
| Akron General Medical Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unity Health Network Llc | 0244379717 | 78 |
News Archive
On-X Life Technologies, Inc. announced today that four clinical trial reports, documenting the On-X Prosthetic Heart Valve's extraordinary performance, will be presented at the upcoming meeting of the Society for Heart Valve Disease in Barcelona, Spain being held June 25-28, 2011.
Physics applies to everything. So when Vittorio Cristini, PhD, started researching cancer, he applied physics. The result he got was a set of mathematical equations that describe, for each person, how many of their tumor cells a cancer treatment could kill.
Silence Therapeutics plc announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various animal models of cancer metastasis. Researchers showed that Atu027 inhibited multiple key biological processes that enable and contribute to the dissemination and formation of pulmonary metastases in a murine breast cancer metastasis model.
Leading alcohol researchers from the United States and Canada will discuss their latest findings at an all-day meeting Nov. 18 at Loyola University Chicago Stritch School of Medicine.
› Verified 9 days ago
| Entity Name | Unity Health Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205169836 PECOS PAC ID: 0244379717 Enrollment ID: O20091124000005 |
News Archive
On-X Life Technologies, Inc. announced today that four clinical trial reports, documenting the On-X Prosthetic Heart Valve's extraordinary performance, will be presented at the upcoming meeting of the Society for Heart Valve Disease in Barcelona, Spain being held June 25-28, 2011.
Physics applies to everything. So when Vittorio Cristini, PhD, started researching cancer, he applied physics. The result he got was a set of mathematical equations that describe, for each person, how many of their tumor cells a cancer treatment could kill.
Silence Therapeutics plc announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various animal models of cancer metastasis. Researchers showed that Atu027 inhibited multiple key biological processes that enable and contribute to the dissemination and formation of pulmonary metastases in a murine breast cancer metastasis model.
Leading alcohol researchers from the United States and Canada will discuss their latest findings at an all-day meeting Nov. 18 at Loyola University Chicago Stritch School of Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence M Saltis, MD 701 White Pond Dr, Suite 300, Akron, OH 44320-1127 Ph: (330) 572-1011 | Lawrence M Saltis, MD 701 White Pond Dr, Suite 300, Akron, OH 44320-1127 Ph: (330) 572-1011 |
News Archive
On-X Life Technologies, Inc. announced today that four clinical trial reports, documenting the On-X Prosthetic Heart Valve's extraordinary performance, will be presented at the upcoming meeting of the Society for Heart Valve Disease in Barcelona, Spain being held June 25-28, 2011.
Physics applies to everything. So when Vittorio Cristini, PhD, started researching cancer, he applied physics. The result he got was a set of mathematical equations that describe, for each person, how many of their tumor cells a cancer treatment could kill.
Silence Therapeutics plc announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various animal models of cancer metastasis. Researchers showed that Atu027 inhibited multiple key biological processes that enable and contribute to the dissemination and formation of pulmonary metastases in a murine breast cancer metastasis model.
Leading alcohol researchers from the United States and Canada will discuss their latest findings at an all-day meeting Nov. 18 at Loyola University Chicago Stritch School of Medicine.
› Verified 9 days ago
Margaret C Mcbride, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 | |
Dr. Marnie Alexandra Mcgrath, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, #400, Akron, OH 44310 Phone: 330-344-6440 | |
Thiruvengadam Kulasekaran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Locust St, Suite 150, Akron, OH 44302 Phone: 330-253-2113 Fax: 330-253-2362 | |
Ann Christina Ciancone, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, Akron, OH 44333 Phone: 330-665-8168 Fax: 330-665-8087 | |
Sumru Bilge-johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-4382 Fax: 330-543-3856 | |
Dr. Christopher Michael Durner, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 N Main St, Akron, OH 44310 Phone: 330-379-5235 Fax: 330-379-9226 | |
Dr. Eileen M Schwartz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 150 Cross Street, Akron, OH 44311 Phone: 330-253-9388 Fax: 330-376-6726 |